Certification of death from ischaemic heart disease in Belfast

Insights

This study found that death certificate data for ischaemic heart disease (IHD) in Belfast was generally accurate. However, only 19% of IHD deaths were confirmed as definite myocardial infarction.

Area of Science:

  • Cardiology
  • Public Health
  • Mortality Statistics

Background:

  • Ischaemic heart disease (IHD) is a significant cause of mortality.
  • Accurate classification of IHD deaths is crucial for public health surveillance and resource allocation.
  • International Classification of Diseases (ICD) codes are used to categorize causes of death.

Purpose of the Study:

  • To assess the accuracy of ischaemic heart disease (IHD) death registrations in Belfast.
  • To determine the proportion of IHD deaths accurately classified using ICD codes (specifically ICD Nos 410-414).
  • To evaluate the reliability of coding for acute myocardial infarction (AMI) within IHD deaths.

Main Methods:

  • Retrospective analysis of all death certificates for Belfast residents over a one-year period (July 1981-July 1982).
  • Cross-referencing death certificate data with hospital records, ECGs, cardiac enzyme results, post-mortems, and general practitioner information.
  • Exclusion and inclusion of deaths based on ICD coding (9th revision) and World Health Organization (WHO) criteria for myocardial infarction.

Main Results:

  • 1654 death certificates were initially examined for potential ischaemic heart disease (IHD).
  • After exclusions and adjustments, the total number of IHD deaths was found to be reasonably accurate for Belfast.
  • For deaths coded under ICD Nos 410-414, only 19% met the WHO criteria for definite myocardial infarction, with 76% coded specifically as acute myocardial infarction (ICD No 410).

Conclusions:

  • The overall recording of deaths due to ischaemic heart disease (IHD) in Belfast is considered reasonably accurate.
  • There is a notable discrepancy between deaths registered as IHD and those definitively classified as myocardial infarction.
  • Further refinement in diagnostic criteria and coding practices for myocardial infarction may be warranted.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...